消費者ヘルスケアの世界市場:市販薬、ダイエットサプリメント...市場調査レポートについてご紹介

【英文タイトル】Global Consumer Healthcare Market 2016-2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Overview: Consumer healthcare market
• OTC pharmaceuticals
• Dietary supplements
• Key buying criteria
• Factors influencing go-to-market strategy

PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 07: Market segmentation by consumer healthcare products
• OTC pharmaceuticals
• Dietary supplements

PART 08: Geographical segmentation
• Global consumer healthcare market by geographical segmentation 2016-2020
• Consumer healthcare market in Americas
• Consumer healthcare market in APAC
• Consumer healthcare market in EMEA

PART 09: Key leading countries
• US
• China
• Japan

PART 10: Market drivers
• Awareness about lifestyle diseases
• Increase in self-medication
• Growing older population
• Rise in disposable income
• Increase in switch from prescription to OTC products

PART 11: Impact of drivers

PART 12: Market challenges
• Intense competition
• Lack of valid literature
• Adverse effects
• Counterfeit pharmaceuticals
• Stringent regulations and guidelines

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Accelerated use of online resources
• New product launches
• Promotions and marketing initiatives
• Strategic alliances

PART 15: Vendor landscape
• Competitive scenario
• Market share 2015

PART 16: Key vendor analysis
• Johnson & Johnson
• Bayer HealthCare
• GlaxoSmithKline
• Sanofi
• Pfizer
• Boehringer Ingelheim
• Other prominent vendors

PART 17: Appendix
• List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Types of consumer healthcare products
Exhibit 03: Key regulatory bodies that approve OTC products
Exhibit 04: FDA OTC drug approval process
Exhibit 05: Mechanisms to amend OTC drug monograph
Exhibit 06: Comparison of OTC NDA versus OTC monograph process
Exhibit 07: Strategies to establish OTC pharmaceuticals in emerging markets
Exhibit 08: Recommendation of dietary supplements by health professionals
Exhibit 09: Key buying criteria in global consumer healthcare market
Exhibit 10: Factors that influence the go-to-market strategy in global consumer healthcare market
Exhibit 11: Global consumer healthcare market 2015-2020 ($ billions)
Exhibit 12: Five forces analysis
Exhibit 13: Segmentation of global consumer healthcare market by products
Exhibit 14: Global OTC pharmaceuticals market 2015-2020 ($ billions)
Exhibit 15: Global OTC pharmaceuticals market by geography 2015
Exhibit 16: Segmentation of global OTC pharmaceuticals by therapeutic class
Exhibit 17: Global OTC pharmaceuticals market segmentation by therapeutic class 2015
Exhibit 18: Drivers and challenges of global OTC pharmaceuticals market
Exhibit 19: Global dietary supplements market 2015-2020 ($ billions)
Exhibit 20: Global dietary supplements market by geography 2015
Exhibit 21: Segmentation of global dietary supplements market by product type
Exhibit 22: Global dietary supplements market by product type 2015
Exhibit 23: Drivers and challenges of global dietary supplements market
Exhibit 24: Segmentation of global consumer healthcare market by geography 2015
Exhibit 25: Global consumer healthcare market revenue by geography 2015-2020 ($ billions)
Exhibit 26: Global consumer healthcare market revenue by geography 2015-2020
Exhibit 27: Consumer healthcare market in Americas 2015-2020 ($ billions)
Exhibit 28: Consumer healthcare market in APAC 2015-2020 ($ billions)
Exhibit 29: Consumer healthcare market in EMEA 2015-2020 ($ billions)
Exhibit 30: Key leading countries in global consumer healthcare market
Exhibit 31: Drivers and challenges
Exhibit 32: Drivers and challenges
Exhibit 33: Drivers and challenges
Exhibit 34: Impact of drivers
Exhibit 35: Impact of drivers and challenges
Exhibit 36: Global internet penetration rate 2015
Exhibit 37: Johnson & Johnson: Business segmentation by revenue 2014
Exhibit 38: Johnson & Johnson: YoY growth rate and revenue of consumer healthcare segment 2012-2014 ($ billions)
Exhibit 39: Johnson & Johnson: Consumer healthcare product categories by revenue 2014
Exhibit 40: Johnson & Johnson: YOY growth rate and revenue of OTC products 2012-2014 ($ billions)
Exhibit 41: Johnson & Johnson: YoY growth rate and revenue of skin care products 2012-2014 ($ billions)
Exhibit 42: Johnson & Johnson: YoY growth rate and revenue of baby care products 2012-2014 ($ billions)
Exhibit 43: Johnson & Johnson: YoY growth rate and revenue of oral care category 2012-2014 ($ billions)
Exhibit 44: Johnson & Johnson: YoY growth rate and revenue of wound care/other products 2012-2014 ($ billions)
Exhibit 45: Johnson & Johnson: YoY growth rate and revenue of women’s health products 2012-2014 ($ billions)
Exhibit 46: Johnson & Johnson: Geographical segmentation by consumer healthcare revenue 2014
Exhibit 47: Johnson & Johnson: SWOT analysis
Exhibit 48: Bayer HealthCare: Business segmentation by revenue 2014
Exhibit 49: Bayer HealthCare: Consumer health segmentation by revenue 2014
Exhibit 50: Bayer HealthCare: Geographic segmentation of consumer healthcare segment 2014
Exhibit 51: Bayer HealthCare: YoY growth rate and revenue of Contour 2012-2014 ($ millions)
Exhibit 52: Bayer HealthCare: YoY growth rate and revenue of Advantage 2012-2014 ($ millions)
Exhibit 53: Bayer HealthCare: YoY growth rate and revenue of Aspirin 2012-2014 ($ millions)
Exhibit 54: Bayer HealthCare: YoY growth rate and revenue of Aleve 2012-2014 ($ millions)
Exhibit 55: Bayer HealthCare: YoY growth rate and revenue of Bepanthen/Bepanthol 2012-2014 ($ millions)
Exhibit 56: Bayer Healthcare: SWOT analysis
Exhibit 57: GlaxoSmithKline: Business segmentation by revenue 2014
Exhibit 58: GlaxoSmithKline: YoY growth rate and revenue of consumer healthcare segment 2012-2014 ($ billions)
Exhibit 59: GlaxoSmithKline: Segmentation of consumer healthcare categories by revenue 2012-2014
Exhibit 60: GlaxoSmithKline: YoY growth rate and revenue of oral health products 2012-2014 ($ billions)
Exhibit 61: GlaxoSmithKline: YoY growth rate and revenue of wellness products 2012-2014 ($ billions)
Exhibit 62: GlaxoSmithKline: YoY growth rate and revenue of nutrition products 2012-2014 ($ millions)
Exhibit 63: GlaxoSmithKline: YoY growth rate and revenue of skin health category 2012-2014 ($ millions)
Exhibit 64: GlaxoSmithKline: Geographical segmentation by consumer health revenue 2014
Exhibit 65: GlaxoSmithKline: SWOT analysis
Exhibit 66: Sanofi: Business segmentation by revenue 2014
Exhibit 67: Sanofi: Pharmaceutical segment by revenue 2014
Exhibit 68: Sanofi: Geographical segmentation by consumer healthcare revenue 2014
Exhibit 69: Sanofi: YoY growth rate and revenue of Allegra 2012-2014 ($ millions)
Exhibit 70: Sanofi: YoY growth rate and revenue of Doliprane 2012-2014 ($ millions)
Exhibit 71: Sanofi: YoY growth rate and revenue of Essentiale 2012-2014 ($ millions)
Exhibit 72: Sanofi: YoY growth rate and revenue of Enterogermina 2012-2014 ($ millions)
Exhibit 73: Sanofi: YoY revenue comparison of Nasacort 2013 and 2014 ($ millions)
Exhibit 74: Sanofi: SWOT Analysis
Exhibit 75: Pfizer: Business segmentation by revenue 2014
Exhibit 76: Pfizer: Global vaccines, oncology, and consumer healthcare segment by revenue 2014
Exhibit 77: Pfizer: YoY growth rate and revenue of consumer healthcare category 2012-2014 ($ billions)
Exhibit 78: Pfizer: SWOT analysis
Exhibit 79: Boehringer Ingelheim: Business segmentation by revenue 2014
Exhibit 80: Boehringer Ingelheim: YoY revenue and growth rate of Buscopan 2012-2014 ($ millions)
Exhibit 81: Boehringer Ingelheim: YoY revenue and growth rate of Dulcolax 2012-2014 ($ millions)
Exhibit 82: Boehringer Ingelheim: YoY revenue and growth rate of Mucosolvan 2012-2014 ($ millions)
Exhibit 83: Boehringer Ingelheim: YoY revenue and growth rate of Pharmaton 2012-2014 ($ millions)
Exhibit 84: Boehringer Ingelheim: SWOT analysis


【レポート販売概要】

■ タイトル:消費者ヘルスケアの世界市場:市販薬、ダイエットサプリメント
■ 英文:Global Consumer Healthcare Market 2016-2020
■ 発行日:2016年2月24日
■ 調査会社:Technavio
■ 商品コード:IRTNTR8817
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。